{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T09:28:40Z","timestamp":1780824520709,"version":"3.54.1"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016302","name":"Coalition for Epidemic Preparedness Innovations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016302","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Outbreaks of zoonotic emerging infectious diseases, including viral hemorrhagic fevers, are increasing in frequency. Clinical detection remains challenging due to the lack of pathognomonic signs or symptoms and limited access to diagnostics. To better understand the prevalence of prior exposure to viral hemorrhagic fever viruses, serum from community participants in rural Liberia was tested for immunoglobulin G antibodies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Serum collected from individuals enrolled in the ENABLE study, an observational study of Lassa fever virus incidence and seroprevalence, were analyzed for immunoglobulin G against Ebola virus, Marburg virus, Lassa virus, Rift Valley Fever virus, Crimean-Congo hemorrhagic fever virus, pan-alphavirus, and pan-flavivirus by MAGPIX, a multiplex immune assay. Associations with seropositivity were evaluated using questionnaires that included demographic, animal, and environmental exposure information.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eighty-eight percent of samples from 456 participants tested positive for \u22651 of the viral antibodies with a majority (63%) having antibodies to \u22652 viruses. Seropositivity was highest for Lassa virus (67%) followed by pan-flavivirus (51%), pan-alphavirus (35%), Crimean-Congo hemorrhagic fever virus (24%), Ebolavirus (13%), Rift Valley Fever virus (9%), and Marburg virus (8%). Older age, sex (variable by pathogen), and exposure to cats and rats were associated with seropositivity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings demonstrate a significant spillover of filoviruses, bunyaviruses, flaviviruses, and alphaviruses in rural Liberia in contrast with an absence of detected outbreaks. These data support the need for enhanced surveillance and understanding of the ecological and behavioral risk factors for zoonotic spillover events, across a spectrum of disease presentation, given their potential and ongoing threat to global public health.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofag100","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:40:36Z","timestamp":1772109636000},"source":"Crossref","is-referenced-by-count":1,"title":["Serologic Evidence of Hemorrhagic Fever Virus Spillover in Rural Liberia"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9840-5132","authenticated-orcid":false,"given":"Adam M","family":"Schafer","sequence":"first","affiliation":[{"name":"Institute for Global Health and Infectious Diseases, The University of North Carolina , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Kerkula","sequence":"additional","affiliation":[{"name":"The University of North Carolina Institute for Global Health and Infectious Diseases, Project Liberia, , Bong ,","place":["Liberia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4828-9416","authenticated-orcid":false,"given":"Chanhwa","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Gillings School of Global Public Health, The University of North Carolina , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Flomo","sequence":"additional","affiliation":[{"name":"The University of North Carolina Institute for Global Health and Infectious Diseases, Project Liberia, , Bong ,","place":["Liberia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amara","family":"Fofana","sequence":"additional","affiliation":[{"name":"The University of North Carolina Institute for Global Health and Infectious Diseases, Project Liberia, , Bong ,","place":["Liberia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Kerkula","sequence":"additional","affiliation":[{"name":"The University of North Carolina Institute for Global Health and Infectious Diseases, Project Liberia, , Bong ,","place":["Liberia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Sumo","sequence":"additional","affiliation":[{"name":"The University of North Carolina Institute for Global Health and Infectious Diseases, Project Liberia, , Bong ,","place":["Liberia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Sampson","sequence":"additional","affiliation":[{"name":"The University of North Carolina Institute for Global Health and Infectious Diseases, Project Liberia, , Bong ,","place":["Liberia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Vouh","sequence":"additional","affiliation":[{"name":"The University of North Carolina Institute for Global Health and Infectious Diseases, Project Liberia, , Bong ,","place":["Liberia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Flomo","sequence":"additional","affiliation":[{"name":"The University of North Carolina Institute for Global Health and Infectious Diseases, Project Liberia, , Bong ,","place":["Liberia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7141-1179","authenticated-orcid":false,"given":"McKenzie A","family":"Colt","sequence":"additional","affiliation":[{"name":"The University of North Carolina Institute for Global Health and Infectious Diseases, Project Liberia, , Bong ,","place":["Liberia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8592-5154","authenticated-orcid":false,"given":"Katie R","family":"Mollan","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Gillings School of Global Public Health, The University of North Carolina , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7410-8370","authenticated-orcid":false,"given":"Taylor J","family":"Krajewski","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Gillings School of Global Public Health, The University of North Carolina , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9606-4606","authenticated-orcid":false,"given":"Eleanor Rose","family":"Watts","sequence":"additional","affiliation":[{"name":"UK Health Security Agency Vaccine Development and Evaluation Centre, , Andover, England ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Nimely","sequence":"additional","affiliation":[{"name":"The University of North Carolina Institute for Global Health and Infectious Diseases, Project Liberia, , Bong ,","place":["Liberia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randal J","family":"Schoepp","sequence":"additional","affiliation":[{"name":"Diagnostic Systems Division, US Army Medical Research Institute of Infectious Diseases , Fort Detrick, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2854-9308","authenticated-orcid":false,"given":"Keersten","family":"Ricks","sequence":"additional","affiliation":[{"name":"Diagnostic Systems Division, US Army Medical Research Institute of Infectious Diseases , Fort Detrick, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minnie","family":"Ricks","sequence":"additional","affiliation":[{"name":"Phebe Hospital Department of Pediatrics, , Bong ,","place":["Liberia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jefferson","family":"Sibley","sequence":"additional","affiliation":[{"name":"Phebe Hospital Department of Pediatrics, , Bong ,","place":["Liberia"]},{"name":"Phebe Hospital Department of Surgery, , Bong ,","place":["Liberia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6560-1494","authenticated-orcid":false,"given":"Jacob A","family":"Dillard","sequence":"additional","affiliation":[{"name":"The University of North Carolina School of Medicine Department of Microbiology and Immunology, , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Wohl","sequence":"additional","affiliation":[{"name":"Institute for Global Health and Infectious Diseases, The University of North Carolina , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4900-098X","authenticated-orcid":false,"suffix":"II","given":"William A","family":"Fischer","sequence":"additional","affiliation":[{"name":"Institute for Global Health and Infectious Diseases, The University of North Carolina , Chapel Hill, North Carolina ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"2026032415580204200_ofag100-B1","author":"Risk factors for human disease emergence"},{"key":"2026032415580204200_ofag100-B2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.12703\/r\/11-2","article-title":"Emergence of epidemic diseases: zoonoses and other origins","volume":"11","author":"Weiss","year":"2022","journal-title":"Fac Rev"},{"key":"2026032415580204200_ofag100-B3","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/nature06536","article-title":"Global trends in emerging infectious diseases","volume":"451","author":"Jones","year":"2008","journal-title":"Nature"},{"key":"2026032415580204200_ofag100-B4"},{"key":"2026032415580204200_ofag100-B5"},{"key":"2026032415580204200_ofag100-B6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/1099800403252603","article-title":"A current review of Ebola virus: pathogenesis, clinical presentation, and diagnostic assessment","volume":"4","author":"Casillas","year":"2003","journal-title":"Biol Res Nurs"},{"key":"2026032415580204200_ofag100-B7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-020-0147-3","article-title":"Ebola virus disease","volume":"6","author":"Jacob","year":"2020","journal-title":"Nat Rev Dis Primer"},{"key":"2026032415580204200_ofag100-B8","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/bmj.311.7009.857","article-title":"Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice","volume":"311","author":"Fisher-Hoch","year":"1995","journal-title":"BMJ"},{"key":"2026032415580204200_ofag100-B9","doi-asserted-by":"crossref","first-page":"e2748","DOI":"10.1371\/journal.pntd.0002748","article-title":"Lassa fever in post-conflict Sierra Leone","volume":"8","author":"Shaffer","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2026032415580204200_ofag100-B10","doi-asserted-by":"crossref","first-page":"e0283643","DOI":"10.1371\/journal.pone.0283643","article-title":"A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the ENABLE Lassa research programme)-study protocol","volume":"18","author":"Penfold","year":"2023","journal-title":"PLoS One"},{"key":"2026032415580204200_ofag100-B11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12985-016-0621-4","article-title":"Serosurveillance of viral pathogens circulating in West Africa","volume":"13","author":"O\u2019Hearn","year":"2016","journal-title":"Virol J"},{"key":"2026032415580204200_ofag100-B12","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.3201\/eid2706.203223","article-title":"Seroepidemiologic survey of Crimean-Congo hemorrhagic fever virus in logging communities, Myanmar","volume":"27","author":"Evans","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"2026032415580204200_ofag100-B13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijid.2023.03.049","article-title":"Prevalence of immunoglobulin G and M to SARS-CoV-2 and other human coronaviruses in the democratic Republic of Congo, Sierra Leone, and Uganda: a longitudinal study","volume":"131","author":"Lawal","year":"2023","journal-title":"Int J Infect Dis"},{"key":"2026032415580204200_ofag100-B14","doi-asserted-by":"crossref","first-page":"5529347","DOI":"10.1155\/tbed\/5529347","article-title":"Evaluation of a Luminex-based multiplex immunoassay of hemorrhagic fever viruses in Senegal","volume":"2025","author":"Sankhe","year":"2025","journal-title":"Transbound Emerg Dis"},{"key":"2026032415580204200_ofag100-B15","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3390\/v15030790","article-title":"One health surveillance highlights circulation of viruses with zoonotic potential in bats, pigs, and humans in Viet Nam","volume":"15","author":"Latinne","year":"2023","journal-title":"Viruses"},{"key":"2026032415580204200_ofag100-B16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/00273171.2016.1167008","article-title":"Modeling clustered data with very few clusters","volume":"51","author":"McNeish","year":"2016","journal-title":"Multivar Behav Res"},{"key":"2026032415580204200_ofag100-B17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3201\/eid2204.151814","article-title":"Lassa virus seroprevalence in Sibirilia Commune, Bougouni District, Southern Mali","volume":"22","author":"Sogoba","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"2026032415580204200_ofag100-B18","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3201\/eid2902.212525","article-title":"Influence of landscape patterns on exposure to Lassa fever virus, Guinea","volume":"29","author":"Longet","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"2026032415580204200_ofag100-B19","doi-asserted-by":"publisher","author":"Sama","DOI":"10.1017\/S095026882400164X"},{"key":"2026032415580204200_ofag100-B20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-ento-010715-023819","article-title":"Rift valley fever: an emerging mosquito-borne disease","volume":"61","author":"Linthicum","year":"2016","journal-title":"Annu Rev Entomol"},{"key":"2026032415580204200_ofag100-B21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1309\/LMN1P2FRZ7BKZSCO","article-title":"Crimean-Congo hemorrhagic fever","volume":"46","author":"Shayan","year":"2015","journal-title":"Lab Med"},{"key":"2026032415580204200_ofag100-B22"},{"key":"2026032415580204200_ofag100-B23","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3390\/pathogens14121219","article-title":"Seroprevalence of Crimean-Congo hemorrhagic fever and Rift Valley fever viruses among ruminants in Nigeria: a descriptive epizootiological analysis","volume":"14","author":"Ehizibolo","year":"2025","journal-title":"Pathogens"},{"key":"2026032415580204200_ofag100-B24","doi-asserted-by":"crossref","first-page":"101040","DOI":"10.1016\/j.onehlt.2025.101040","article-title":"Re-emergence of Crimean Congo hemorrhagic fever virus in Kedougou, south-eastern Senegal in 2023: Epidemiological and zoological investigations of the first symptomatic human case","volume":"20","author":"Sadio","year":"2025","journal-title":"One Health"},{"key":"2026032415580204200_ofag100-B25","doi-asserted-by":"crossref","first-page":"107524","DOI":"10.1016\/j.actatropica.2025.107524","article-title":"Serological evidence of Crimean-Congo haemorrhagic fever in domestic animals from eight regions of Namibia","volume":"262","author":"de Villiers","year":"2025","journal-title":"Acta Trop"},{"key":"2026032415580204200_ofag100-B26","doi-asserted-by":"crossref","first-page":"1423474","DOI":"10.3389\/fimmu.2024.1423474","article-title":"Serological cross-reactivity between Crimean-Congo haemorrhagic fever virus and Nairobi sheep disease virus glycoprotein C","volume":"15","author":"Maze","year":"2025","journal-title":"Front Immunol"},{"key":"2026032415580204200_ofag100-B27","doi-asserted-by":"crossref","first-page":"e02156","DOI":"10.1128\/JVI.02156-20","article-title":"Cross-reactive anti-nucleocapsid protein immunity against Crimean-Congo hemorrhagic fever virus and Hazara virus in multiple Species","volume":"95","author":"Kalkan-Yaz\u0131c\u0131","year":"2021","journal-title":"J Virol"},{"key":"2026032415580204200_ofag100-B28","doi-asserted-by":"crossref","first-page":"e0008699","DOI":"10.1371\/journal.pntd.0008699","article-title":"Development of a multiplex microsphere immunoassay for the detection of antibodies against highly pathogenic viruses in human and animal serum samples","volume":"14","author":"Surtees","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"2026032415580204200_ofag100-B29"},{"key":"2026032415580204200_ofag100-B30","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1805435","article-title":"A longitudinal study of Ebola sequelae in Liberia","volume":"380","author":"PREVAIL III Study Group","year":"2019","journal-title":"N Engl J Med"},{"key":"2026032415580204200_ofag100-B31","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cell.2015.12.022","article-title":"Cross-reactive and potent neutralizing antibody responses in human survivors of natural Ebolavirus infection","volume":"164","author":"Flyak","year":"2016","journal-title":"Cell"},{"key":"2026032415580204200_ofag100-B32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0035-9203(77)90210-3","article-title":"Dengue virus infections in Nigeria: a survey for antibodies in monkeys and humans","volume":"71","author":"Fagbami","year":"1977","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2026032415580204200_ofag100-B33","first-page":"1349","article-title":"Dengue virus infection in Africa","volume":"17","author":"Amarasinghe","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"2026032415580204200_ofag100-B34","first-page":"371","article-title":"Seroprevalence and distribution of Flaviviridae, Togaviridae, and Bunyaviridae arboviral infections in rural Cameroonian adults","volume":"75","author":"Kuniholm","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"2026032415580204200_ofag100-B35","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/JCM.01693-16","article-title":"Comparison of MagPix assays and enzyme-linked immunosorbent assay for detection of hemorrhagic fever viruses","volume":"55","author":"Satterly","year":"2017","journal-title":"J Clin Microbiol"},{"key":"2026032415580204200_ofag100-B36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/irv.12449","article-title":"Novel multiplex assay platforms to detect influenza A hemagglutinin subtype-specific antibody responses for high-throughput and in-field applications","volume":"11","author":"Li","year":"2017","journal-title":"Influenza Other Respir Viruses"},{"key":"2026032415580204200_ofag100-B37","doi-asserted-by":"crossref","first-page":"e01731","DOI":"10.1128\/JCM.01731-20","article-title":"Highly sensitive and specific multiplex antibody assays to quantify immunoglobulins M, A, and G against SARS-CoV-2 antigens","volume":"59","author":"Doba\u00f1o","year":"2021","journal-title":"J Clin Microbiol"},{"key":"2026032415580204200_ofag100-B38","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/infdis\/jiae395","article-title":"A longitudinal analysis of memory immune responses in convalescent Crimean-Congo hemorrhagic fever survivors in Uganda","volume":"231","author":"Cohen","year":"2025","journal-title":"J Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofag100\/67226212\/ofag100.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/3\/ofag100\/67226212\/ofag100.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/3\/ofag100\/67226212\/ofag100.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T19:58:14Z","timestamp":1774382294000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag100\/8505712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag100","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2026,3]]},"article-number":"ofag100"}}